Navigation Links
Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
Date:6/19/2012

SAN DIEGO, June 19, 2012 /PRNewswire/ -- Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea's Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton brings 35 years of experience in the biotechnology and pharmaceutical industries to this role.  Starting his career at Pfizer Central Research, he subsequently joined Amgen at its inception, where during his 26 year tenure, he helped transform the company from a small biotech to a global leader in the industry.  Dr. Fenton's career is distinguished by his strong track record of scientific expertise and innovation; he also holds 5 US patents in microbiology and has published over 50 papers and abstracts.

(Logo: http://photos.prnewswire.com/prnh/20020925/LAW010LOGO)

"Althea Technologies is very fortunate to be welcoming such an accomplished industry leader to chair its Scientific Advisory Board," said Dr. Magda Marquet, Founder and Co-Chair of Althea Technologies.

"Dennis Fenton has been a pioneer in translating biologic discoveries to high volume commercial production, and his expanded role supports Althea's commitment to provide its clients with state of the art clinical and commercial biologic manufacturing solutions," said Matt Mackowski, Co-Chair of Althea Technologies. 

Commenting on his appointment, Dr. Fenton said, "It is an honor to accept the chairman position on Althea's Scientific Advisory Board.  I am excited to contribute my experience in microbiology research within the pharmaceutical industry to Althea's continued growth as a provider of quality biologics development and manufacturing services."

Dr. Fenton retired from Amgen in 2008 and has since worked as an independent consultant.  Additionally, he has been the member of the boards of Amira, CytomX, Dendreon, Genelux, Genzyme, Kythera, Napo, Xenoport, Rutgers University, the Keck graduate Institute and the Biotechnology Institute.  Dr. Fenton received his Ph.D. in Microbiology from Rutgers University.

Althea Technologies' current Scientific Advisory Board consists of Dr. Steve Kay, Dr. Daniel Wang, and Jeff Yuen.

About Althea Technologies

Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services. Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. Althea's formulation technology platform includes Crystalomics®, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. For more information, visit www.altheatech.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. UV Flu Technologies Expands Its International Footprint
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
7. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
8. Animal Biotechnology - Technologies, Markets and Companies
9. Gene Therapy - Technologies, Markets and Companies
10. Biomarkers - Technologies, Markets and Companies
11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 21, 2017 , ... ... peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered by the ... feed pumps in SU tangential flow filtration (TFF), virus filtration (VF) and ...
(Date:3/22/2017)... Israel , March 22, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced today ... provide an update on new developments and a corporate ... Biopartnering and Investment Forum, being held on March 27 ... Neuroscience Biopartnering ...
(Date:3/20/2017)... ... 20, 2017 , ... SSCI and Whitehouse Laboratories, divisions of Albany Molecular Research, ... Sponsored by the Parenteral Drug Association (PDA), the New York Interphex Show will open ... attendance and more than 625 exhibitors, the educational and networking opportunities are extremely valuable. ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... laborious sample preparation methods in order to reduce the impact on instrumentation. ICP-MS ... the area of elemental analysis. , This presentation will discuss the pros ...
Breaking Biology Technology:
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
(Date:3/9/2017)... , March 9, 2017 4Dx has ... World Lung Imaging Workshop at the University of Pennsylvania. ... invited to deliver the latest data to world leaders ... event brings together leaders at the forefront of the ... lung imaging. "The quality of the ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
Breaking Biology News(10 mins):